Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis.
about
Macrophage activation syndrome: advances towards understanding pathogenesisSoluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions.Perforin: structure, function, and role in human immunopathology.Systemic arthritis in children: a review of clinical presentation and treatmentIs Still's Disease an Autoinflammatory Syndrome?Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.Application of the Yamaguchi criteria for classification of "suspected" systemic juvenile idiopathic arthritis (sJIA).Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy.Natural killer cells in human autoimmune disordersTocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis.What do cytokine profiles tell us about subsets of juvenile idiopathic arthritis?Tocilizumab in pediatric rheumatology: the clinical experience.Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome".Macrophage activation syndrome and cytokine-directed therapies.Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations.Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.Inflammatory Gene Expression Profile and Defective Interferon-γ and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients.Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era.New frontiers in the treatment of systemic juvenile idiopathic arthritis.Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis.[Still's disease in children and adults].Paediatric rheumatic disease: Diagnosing macrophage activation syndrome in systemic JIA.Signalling in the genomic era.Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis.Role of cytolytic impairment of natural killer and natural killer T-cell populations in rheumatoid arthritis.Interleukin-18: Biological properties and role in disease pathogenesis.Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by γ/δ T Cells in Systemic Juvenile Idiopathic Arthritis.Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study.Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition.
P2860
Q28284000-A65C752F-8894-4645-85D0-E85070DFCCA7Q33412621-7771CC68-0430-4486-AF3D-8155C372ADB9Q34042413-287C39BD-0DE0-4E3C-80D6-168374709472Q34269827-2326DF9A-FE08-4DAD-BB00-9BC4E9B50C3FQ34620426-AB04819C-A472-46AF-9D30-F487C03D68B5Q35659928-B4E07387-E587-44B2-B2C6-7DF8C641B88DQ35955190-19BA2EE6-3F58-483C-BBB3-D3498AA39C05Q36041225-C0A0FE54-002F-414F-AA54-98B67AAC6AA4Q36552413-3A378F97-E91C-456C-B6A1-BEE4AE79D84FQ37602644-505A41B2-B7D3-4885-8F11-3285BA263AF9Q37690952-4C8A08C8-E754-4813-92B9-EC34FD8116AAQ37786628-55DA3ACD-96B7-4C9A-BB23-D2B61FCFA16EQ37975164-2900A358-0702-4BB9-A1B0-6072199F70A7Q38110210-3029D8A1-23C9-41EF-9F2A-62A56CA4D1F4Q38212949-1FB8DB65-B49E-4BF6-8776-55A5663117B8Q38224085-F9095D2E-2B26-486F-9A7A-1BD03EF4E21FQ38267068-F1A16AA8-8B0A-492A-B9B6-9F49422FE910Q38406386-A1AF2DCE-AE8F-421E-B9D4-0EC37326947BQ38648790-10D9E83A-2AC8-494F-997E-2E7B1F7EB587Q38742750-6B5E522C-73EB-4758-A86C-6F885A71CFFCQ39144075-3B7DDA98-3B6F-4A22-B53D-2456336E678DQ39424746-011138D5-146F-41BA-A030-BBA491B38C04Q39761819-7696A6D9-4068-4852-9DD0-8F64C8B8D1E0Q40045645-10403C32-29D4-483B-B22F-F2981E5AAAC7Q41747703-B7188FF1-B377-4FFD-9D48-CC7010EE53B5Q42001109-2703E8C3-B682-42E9-B336-30FBCC9AA9CBQ43062304-CE750302-23F2-4DE5-86B3-0404A0C9BCA0Q46897841-EE517CB5-1DA0-42B1-9864-66E6DECC8E31Q47285927-DA799C2D-C978-4514-970C-D9C9F59849E8Q48122220-04C8EDA8-6CAF-48B7-B000-7FBF6D179376Q51740150-F2D32113-31D7-4C44-BBA7-FDE0D30B1D3DQ55417340-CA3686D3-3FC6-428D-BB2D-89D325E7A522
P2860
Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Defective phosphorylation of i ...... juvenile idiopathic arthritis.
@en
Defective phosphorylation of i ...... juvenile idiopathic arthritis.
@nl
type
label
Defective phosphorylation of i ...... juvenile idiopathic arthritis.
@en
Defective phosphorylation of i ...... juvenile idiopathic arthritis.
@nl
prefLabel
Defective phosphorylation of i ...... juvenile idiopathic arthritis.
@en
Defective phosphorylation of i ...... juvenile idiopathic arthritis.
@nl
P2093
P2860
P921
P356
P1476
Defective phosphorylation of i ...... juvenile idiopathic arthritis.
@en
P2093
Berent J Prakken
Jeffrey M Beekman
Nico M Wulffraat
Paul J Coffer
Sebastiaan J Vastert
Wietse Kuis
P2860
P304
P356
10.1002/ART.24750
P577
2009-09-01T00:00:00Z